Literature DB >> 12697595

Comparison of intrathecal isobaric bupivacaine-morphine and ropivacaine-morphine for Caesarean delivery.

C O Oğün1, E N Kirgiz, A Duman, S Okesli, C Akyürek.   

Abstract

BACKGROUND: This study was designed to evaluate the effects of intrathecal isobaric bupivacaine 0.5% plus morphine and isobaric ropivacaine 0.5% plus morphine combinations in women undergoing Caesarean deliveries.
METHOD: Twenty-five parturients received ropivacaine 15 mg and morphine 150 micro g (RM group) and twenty-five parturients received bupivacaine 15 mg and morphine 150 micro g (BM group) for spinal anaesthesia. Sensory and motor block, haemodynamics, postoperative analgesia, fetal outcomes, and side-effects were evaluated.
RESULTS: Intrathecal bupivacaine-morphine and ropivacaine-morphine provided effective sensory anaesthesia and motor block. Time to reach complete motor block was shorter and time to complete recovery from motor block was longer in the BM group than the RM group (P<0.05). The time to regression of two dermatomes and time for the block to recede to the S2 dermatome were similar in both groups (P>0.05). Time to first complaint of pain and the mean total consumption of tenoxicam were similar in both groups (P>0.05). APGAR scores at 1 and 5 min were similar in the two groups, as were mean umbilical blood pH values (P>0.05). Hypotension and pruritus were the most common side-effects in both groups during the operation.
CONCLUSION: Intrathecal isobaric ropivacaine 0.5% 15 mg plus morphine 150 micro g provides sufficient anaesthesia for Caesarean delivery. The ropivacaine-morphine combination resulted in shorter motor block, similar sensory and postoperative analgesia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697595     DOI: 10.1093/bja/aeg123

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  7 in total

1.  Comparative study of fentanyl and morphine in addition to hyperbaric or isobaric bupivacaine in combined spinal anaesthesia for caesarean section.

Authors:  Ayten Saracoglu; Kemal T Saracoglu; Zeynep Eti
Journal:  Arch Med Sci       Date:  2011-09-02       Impact factor: 3.318

2.  Sparing effects of sufentanil on epidural ropivacaine in elderly patients undergoing transurethral resection of prostate surgery.

Authors:  Huiling Li; Yuhong Li; Rui He
Journal:  Yonsei Med J       Date:  2015-05       Impact factor: 2.759

3.  Height-based dosing algorithm of bupivacaine in spinal anaesthesia for decreasing maternal hypotension in caesarean section without prophylactic fluid preloading and vasopressors: study protocol for a randomised controlled non-inferiority trial.

Authors:  Bowan Huang; Qiang Huang; Chao Hai; Zihao Zheng; Yali Li; Zhongjun Zhang
Journal:  BMJ Open       Date:  2019-05-16       Impact factor: 2.692

4.  A Height-Based Dosing Algorithm of Bupivacaine in Spinal Anesthesia for Decreasing Maternal Hypotension in Cesarean Section Without Prophylactic Fluid Preloading and Vasopressors: A Randomized-Controlled Non-Inferiority Trial.

Authors:  Qiang Huang; Gengzhi Wen; Chao Hai; Zihao Zheng; Yali Li; Zengping Huang; Bowan Huang
Journal:  Front Med (Lausanne)       Date:  2022-06-10

5.  Randomised Control Trial Comparing Plain Levobupivacaine and Ropivacaine with Hyperbaric Bupivacaine in Caesarean Deliveries.

Authors:  Divya Sethi
Journal:  Turk J Anaesthesiol Reanim       Date:  2019-09-02

6.  Comparison between intrathecal isobaric ropivacaine-fentanyl and bupivacaine-fentanyl in elective infraumbilical orthopedic surgery: A randomized controlled study.

Authors:  Amitava Layek; Souvik Maitra; Nitish K Gozi; Sulagna Bhattacharjee; Sugata Pal; Suvadeep Sen; Avijit Hazra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Oct-Dec

7.  Comparison of the Efficacy of Intrathecal Isobaric Ropivacaine and Bupivacaine in Day Care Knee Arthroscopy: A Randomized Controlled Trial.

Authors:  S Suresh Kumar; Vandana Talwar; Poonam Gupta; Anoop Raj Gogia
Journal:  Anesth Essays Res       Date:  2018 Oct-Dec
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.